Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Zhou, J; Sun, HC; Wang, Z; Cong, WM; Wang, JH; Zeng, MS; Zhou, WP; Bie, P; Liu, LX; Wen, TF; Han, GH; Wang, MQ; Liu, RB; Lu, LG; Ren, ZG; Chen, MS; Zeng, ZC; Liang, P; Liang, CH; Chen, M; Yan, FH; Wang, WP; Ji, Y; Yun, JP; Cai, DF; Chen, YJ; Cheng, WW; Cheng, SQ; Dai, CL; Guo, WZ; Hua, BJ; Huang, XW; Jia, WD; Li, YM; Li, YX; Liang, J; Liu, TS; Lv, GY; Mao, YL; Peng, T; Ren, WX; Shi, HC; Shi, GM; Tao, KS; Wang, WT; Wang, XY; Wang, ZM; Xiang, BD; Xing, BC; Xu, JM; Yang, JM; Yang, JY; Yang, YF; Yang, YK; Ye, SL; Yin, ZY; Zhang, BX; Zhang, BH; Zhang, LD; Zhang, SJ; Zhang, T; Zhao, YF; Zheng, HG; Zhu, JY; Zhu, KS; Liu, R; Shi, YH; Xiao, YS; Dai, Z; Teng, GJ; Cai, JQ; Wang, WL; Cai, XJ; Li, Q; Shen, F; Qin, SK; Dong, JH; Fan, J

Fan, J (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, 180 Fenglin Rd, Shanghai 200032, Peoples R China.

LIVER CANCER, 2020; 9 (6): 682

Abstract

Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause ......

Full Text Link